Stratrix
On the Record · Walgreens Boots Alliance

Walgreens Boots Alliance acquisitions, on the record

The businesses Walgreens Boots Alliance bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
Innovation Associates, Inc.
Word for word“On December 29, 2020, the Company acquired a majority equity interest in Innovation Associates, Inc. (“iA”) for a cash consideration of $451 million.” 10-K for 2021
acquisitionOn December 29, 2020$451 million
Pharmaceutical wholesale business in Germany (combined with McKesson Corporation)
Word for word“On November 1, 2020, the Company and McKesson Corporation closed a transaction to form a combined pharmaceutical wholesale business in Germany, as part of a strategic alliance.” 10-K for 2021
mergerOn November 1, 2020—
Alliance Healthcare business
Word for word“On June 1, 2021 the Company completed the previously announced sale of the Company’s Alliance Healthcare business and used a portion of the Alliance Healthcare Sale proceeds to repay all borrowings outstanding under the April 2021 Credit Agreement.” 10-K for 2021
divestitureOn June 1, 2021—
Shields
Word for word“On October 29, 2021, the Company completed the acquisition of a majority interest in Shields.” 10-K for 2022
acquisitionOn October 29, 2021—
remaining 30% equity interest in Shields
Word for word“The Company entered into a definitive agreement to acquire the remaining 30% equity interest for approximately $1.37 billion of cash consideration.” 10-K for 2022
agreed acquisition—approximately $1.37 billion
VillageMD
Word for word“On November 24, 2021, the Company completed the acquisition of a majority interest in VillageMD.” 10-K for 2022
acquisitionOn November 24, 2021—
CareCentrix
Word for word“On August 31, 2022, the Company completed the acquisition of a majority interest in CareCentrix.” 10-K for 2022
acquisitionOn August 31, 2022—
remaining 45% equity interest in CareCentrix
Word for word“The Company entered into a definitive agreement to acquire the remaining 45% equity interest for approximately $392 million of cash consideration.” 10-K for 2022
agreed acquisition—approximately $392 million
Guangzhou Pharmaceuticals Company Limited
Word for word“On August 5, 2022, the Company entered into an agreement for the sale of its equity method investment in Guangzhou Pharmaceuticals Company Limited for approximately $150 million.” 10-K for 2022
agreed divestitureOn August 5, 2022approximately $150 million
WP CityMD TopCo ("Summit")
Word for word“Summit acquisition On January 3, 2023, VillageMD, through its parent company, following an internal reorganization, completed the acquisition of WP CityMD TopCo (“Summit”), a provider of primary, specialty and urgent care in exchange, for $7.0 billion aggregate consideration, consisting of $4.85 billion of cash consideration paid, $2.05 billion in preferred units of VillageMD issued to Summit equity holders and $100 million of cash to be paid one year following closing.” 10-K for 2023
acquisitionOn January 3, 2023$7.0 billion aggregate consideration
Farmacias Ahumada business in Chile
Word for word“Sale of Farmacias Ahumada On May 16, 2023, the Company announced that it entered into an agreement to sell the Farmacias Ahumada business in Chile.” 10-K for 2023
agreed divestitureOn May 16, 2023—
Alliance Healthcare business and a portion of the Company's retail pharmacy international businesses in Europe
Word for word“On June 1, 2021, the Company completed the sale of the majority of the Company's Alliance Healthcare business as well as a portion of the Company’s retail pharmacy international businesses in Europe (“Disposal Group”) to Cencora, Inc. (“Cencora”), formerly known as AmerisourceBergen Corporation (“AmerisourceBergen”).” 10-K for 2023
divestitureOn June 1, 2021—
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedCash paid for acquisitions (net of cash acquired)Cash received from selling businessesGoodwill from acquisitions
2016-08-31—$74 million$23 million
2017-08-31—$0$104 million
2018-08-31—$0$1.35 billion
2019-08-31$304 million—$8 million
2020-08-31——$62 million
2021-08-31——$414 million
2022-08-31——$10.04 billion
2023-08-31——$5.59 billion

Deal filings since 2016

Read from Walgreens Boots Alliance’s annual reports (10-K for 2024, 10-K for 2023, 10-K for 2022, 10-K for 2021) and the financial data it files with the SEC, as of 2024-10-15. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.